Ballara S, Taylor P C, Reusch P, Marmé D, Feldmann M, Maini R N, Paleolog E M
Imperial College School of Medicine, London, UK.
Arthritis Rheum. 2001 Sep;44(9):2055-64. doi: 10.1002/1529-0131(200109)44:9<2055::AID-ART355>3.0.CO;2-2.
To determine whether elevated levels of the angiogenic cytokine vascular endothelial growth factor (VEGF), detected on presentation to an early arthritis clinic, are associated with the development of chronic and erosive arthritis.
Concentrations of VEGF and its soluble receptor, soluble fms-like tyrosine kinase 1 (sFlt-1), were measured by enzyme-linked immunosorbent assay in serum samples from patients with early (<2 years from onset) arthritic symptoms in the peripheral joints, namely early rheumatoid arthritis (RA), self-limiting arthritis (viral, reactive, and idiopathic inflammatory arthritis), or psoriatic arthritis. In addition, measurements were made in random samples from patients with longstanding (>3 years from symptom onset) RA treated with disease-modifying antirheumatic drugs, from patients with osteoarthritis (OA), and from patients with polyarthralgia without arthritis, as well as from nonarthritic controls.
Serum VEGF levels at presentation were elevated in patients with inflammatory arthritis (RA, psoriatic, and self-limiting arthritis) as well as in patients with OA, in comparison with nonarthritic controls. Moreover, serum VEGF concentrations were significantly higher in patients with early RA than in patients with self-limiting arthritis. Serum VEGF levels at presentation in patients with early RA correlated significantly with the development of radiographic damage after 1 year. Improvement in the clinical symptoms of RA was associated with a reduction in serum VEGF levels. Serum sFlt-1 levels were raised in patients with early and longstanding RA and in those with self-limiting arthritis, and correlated positively with the serum VEGF concentrations in patients with inflammatory arthritis.
These findings implicate the proangiogenic cytokine VEGF in the persistence of inflammatory arthritis, and support the hypothesis that expansion of the synovial vasculature is important for the development of joint destruction in RA.
确定在早期关节炎诊所就诊时检测到的血管生成细胞因子血管内皮生长因子(VEGF)水平升高是否与慢性侵蚀性关节炎的发生有关。
采用酶联免疫吸附测定法,检测外周关节出现关节炎症状早期(起病<2年)患者血清样本中VEGF及其可溶性受体可溶性fms样酪氨酸激酶1(sFlt-1)的浓度,这些患者包括早期类风湿关节炎(RA)、自限性关节炎(病毒感染性、反应性和特发性炎症性关节炎)或银屑病关节炎患者。此外,还对接受改善病情抗风湿药物治疗的病程较长(症状出现>3年)的RA患者、骨关节炎(OA)患者、无关节炎的多关节痛患者以及非关节炎对照者的随机样本进行了检测。
与非关节炎对照者相比,炎症性关节炎(RA、银屑病关节炎和自限性关节炎)患者以及OA患者就诊时的血清VEGF水平升高。此外,早期RA患者的血清VEGF浓度显著高于自限性关节炎患者。早期RA患者就诊时的血清VEGF水平与1年后影像学损伤的发生显著相关。RA临床症状的改善与血清VEGF水平的降低有关。早期和病程较长的RA患者以及自限性关节炎患者的血清sFlt-1水平升高,且与炎症性关节炎患者的血清VEGF浓度呈正相关。
这些发现表明促血管生成细胞因子VEGF与炎症性关节炎的持续存在有关,并支持滑膜血管扩张对RA关节破坏发展至关重要这一假说。